rs5982618

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000047.3(ARSL):​c.549C>T​(p.Arg183Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00689 in 1,209,080 control chromosomes in the GnomAD database, including 268 homozygotes. There are 2,230 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.031 ( 136 hom., 878 hem., cov: 22)
Exomes 𝑓: 0.0044 ( 132 hom. 1352 hem. )

Consequence

ARSL
NM_000047.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.07

Publications

1 publications found
Variant links:
Genes affected
ARSL (HGNC:719): (arylsulfatase L) Arylsulfatase E is a member of the sulfatase family. It is glycosylated postranslationally and localized to the golgi apparatus. Sulfatases are essential for the correct composition of bone and cartilage matrix. X-linked chondrodysplasia punctata, a disease characterized by abnormalities in cartilage and bone development, has been linked to mutations in this gene. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the Y chromosome. [provided by RefSeq, Sep 2013]
ARSL Gene-Disease associations (from GenCC):
  • X-linked chondrodysplasia punctata 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-2949609-G-A is Benign according to our data. Variant chrX-2949609-G-A is described in ClinVar as Benign. ClinVar VariationId is 157735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARSLNM_000047.3 linkc.549C>T p.Arg183Arg synonymous_variant Exon 6 of 11 ENST00000381134.9 NP_000038.2 P51690

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARSLENST00000381134.9 linkc.549C>T p.Arg183Arg synonymous_variant Exon 6 of 11 1 NM_000047.3 ENSP00000370526.3 P51690

Frequencies

GnomAD3 genomes
AF:
0.0310
AC:
3436
AN:
110827
Hom.:
134
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.00453
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0126
Gnomad NFE
AF:
0.00124
Gnomad OTH
AF:
0.0324
GnomAD2 exomes
AF:
0.0102
AC:
1861
AN:
183238
AF XY:
0.00623
show subpopulations
Gnomad AFR exome
AF:
0.109
Gnomad AMR exome
AF:
0.00898
Gnomad ASJ exome
AF:
0.00441
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00127
Gnomad OTH exome
AF:
0.00750
GnomAD4 exome
AF:
0.00445
AC:
4882
AN:
1098200
Hom.:
132
Cov.:
32
AF XY:
0.00372
AC XY:
1352
AN XY:
363556
show subpopulations
African (AFR)
AF:
0.113
AC:
2986
AN:
26402
American (AMR)
AF:
0.0105
AC:
371
AN:
35196
Ashkenazi Jewish (ASJ)
AF:
0.00438
AC:
85
AN:
19385
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30206
South Asian (SAS)
AF:
0.000499
AC:
27
AN:
54133
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40533
Middle Eastern (MID)
AF:
0.0215
AC:
89
AN:
4134
European-Non Finnish (NFE)
AF:
0.00100
AC:
845
AN:
842119
Other (OTH)
AF:
0.0103
AC:
476
AN:
46092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
243
486
730
973
1216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0311
AC:
3453
AN:
110880
Hom.:
136
Cov.:
22
AF XY:
0.0265
AC XY:
878
AN XY:
33090
show subpopulations
African (AFR)
AF:
0.104
AC:
3152
AN:
30425
American (AMR)
AF:
0.0166
AC:
172
AN:
10358
Ashkenazi Jewish (ASJ)
AF:
0.00453
AC:
12
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3494
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2553
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5981
Middle Eastern (MID)
AF:
0.0138
AC:
3
AN:
218
European-Non Finnish (NFE)
AF:
0.00124
AC:
66
AN:
53017
Other (OTH)
AF:
0.0320
AC:
48
AN:
1501
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
114
227
341
454
568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0177
Hom.:
204
Bravo
AF:
0.0366
EpiCase
AF:
0.00202
EpiControl
AF:
0.00285

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Chondrodysplasia punctata, brachytelephalangic, autosomal Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

X-linked chondrodysplasia punctata 1 Benign:1
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
Nov 01, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.2
DANN
Benign
0.52
PhyloP100
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5982618; hg19: chrX-2867650; API